FACT Chief Medical Officer to Reveal New Accreditation Standards in “Share the Science” Presentation

Mediware’s Share the Science Series highlights NetCord-FACT 6th Edition Cord Blood Standards

LENEXA, Kan., March 18, 2016 – Dr. Phyllis I. Warkentin, chief medical officer for the Foundation for the Accreditation of Cellular Therapy (FACT), will present “A First Look at the NetCord-FACT 6th Edition Cord Blood Standards.” Dr. Warkentin’s presentation is part of the “Share the Science” webinar series sponsored by Mediware Information Systems, Inc., provider of Transtem™ cellular therapy software, and Save the Cord Foundation.

FACT, co-founded by the International Society for Cellular Therapy (ISCT) and the American Society of Blood and Marrow Transplantation (ASBMT), is a nonprofit accrediting organization serving the cellular therapy field. Every three years, FACT leaders review its accreditation standards and update them as needed based on scientific advances, recommendations from cord blood banking experts, and common deficiencies. The new standards will be published in July, but in this original webinar, Dr. Warkentin will preview some of the significant changes, detail why those changes were made, and provide recommendations for complying with the new standards.

Dr. Warkentin has been FACT’s chief medical officer since the organization’s inception. She is also a professor of pathology/microbiology and pediatrics at the University of Nebraska Medical Center (UNMC) College of Medicine and serves as the medical director at UNMC’s Biologics Production Facility. In addition, Dr. Warkentin is board certified in pediatric hematology/oncology and transfusion medicine and is a founding member of the FACT board of directors.

This “Share the Science” webinar will take place on Tuesday, March 22 at noon EST (11 a.m. CST). Register for free at www.Mediware.com/Warkentin.

Both private and public cord blood banks are invited to contact FACT at fact@unmc.edu or 402-559-1950 for more details regarding accreditation.

About Mediware’s Transtem Solution
Mediware® is a leading provider of specialized healthcare solutions with more than four decades of experience developing and delivering innovative software designed to improve efficiencies and address safety concerns while decreasing costs. The Transtem software was designed by cellular therapy professionals to provide a comprehensive solution for cord blood banks, BMT centers, cell therapy labs, and regenerative medicine programs to collect, process, transfuse and track adult and cord blood stem cells used in the treatment of cancer and blood-related diseases. Transtem’s unique laboratory and clinical capabilities operate as a comprehensive suite that seamlessly integrates donor, product and patient data, managing the full continuum of care and providing a 360-degree view of treatments and outcomes.

About Save the Cord Foundation
Save the Cord Foundation’s vision is to make saving umbilical cord blood the standard of care in birthing hospitals across the U.S. and around the globe. Save the Cord Foundation provides non-biased information to expectant parents and the public about the options for saving umbilical cord blood by public donation, private banking and donation to research. A nonprofit, tax-exempt organization, Save the Cord Foundation was established to create and expand cord blood education and create awareness for the need to preserve and share this valuable, lifesaving medical resource.